On November 9, 2020, Eko Devices, Inc., a cardiopulmonary digital health company, announced $65 million in Series C funding led by Highland Capital Partners and Questa Capital, with participation from Artis Ventures, DigiTx Partners, NTTVC, 3M Ventures, and other new and existing investors. The funding will be used to expand in-clinic use of the company’s platform of telehealth and AI algorithms for disease screening, and to launch a monitoring program for cardiopulmonary patients at home.
The WilmerHale team representing Eko included Joe Wyatt, Jason Chipman, Molly Holsinger and Lugar Choi.